Matthew Helmut Kulke, MD
Chief, Hematology/Oncology, Co-Director, Cancer Center
Call for assistance with the referral process
More About Me
Administrative TitleZoltan Kohn Professor of Medicine, Boston University Chobanian & Avedisian School of Medicine. Member, Evans Center for Interdisciplinary Biomedical Research, Boston University. Member, Shipley Prostate Cancer Research Center at Boston University Chobanian & Avedisian School of Medicine.
EducationUniversity of California San Francisco School of Medicine, 1992
ResidencyInternal Medicine, Brigham and Women’s Hospital
FellowshipMedical Oncology, Dana-Farber Cancer Institute
Board CertificationsMedical Oncology, American Board of Internal Medicine
Special InterestsNeuroendocrine tumors, gastrointestinal cancer, carcinoid tumors
Boston University is a leading private research institution with two primary campuses in the heart of Boston and programs around the world.
Latest from HealthCity
CAR T, a personalized cell therapy, has been a game-changer for certain blood cancers, but its high cost has been a huge barrier to equitable access.
A new collaboration among Boston cancer centers aims to increase minority populations’ access to the latest treatments for more equitable outcomes.
At Boston Medical Center, experts from the Cancer Center are exploring how new and existing therapies could fight the COVID infection.